Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Modupe O. V. Osinubi"'
Autor:
Phenix-Lan Quan, Cadhla Firth, Craig Street, Jose A. Henriquez, Alexandra Petrosov, Alla Tashmukhamedova, Stephen K. Hutchison, Michael Egholm, Modupe O. V. Osinubi, Michael Niezgoda, Albert B. Ogunkoya, Thomas Briese, Charles E. Rupprecht, W. Ian Lipkin
Publikováno v:
mBio, Vol 1, Iss 4 (2010)
ABSTRACT Bats are reservoirs for emerging zoonotic viruses that can have a profound impact on human and animal health, including lyssaviruses, filoviruses, paramyxoviruses, and severe acute respiratory syndrome coronaviruses (SARS-CoVs). In the cours
Externí odkaz:
https://doaj.org/article/f6cf8979b0fb4d5d8d39c3e0ff89e1e4
Autor:
Maruf Lawal, Dianna M. Blau, Dana L. Haberling, Philip Paul Mshelbwala, Neil M. Vora, Charles E. Rupprecht, A. B. Ogunkoya, A. M. Ehimiyein, S. W. Audu, Sergio Recuenco, Henry Akpan, Todd G. Smith, Jibrin M. Idris, Elizabeth Adedire, Mariat O Soleye, Michael Niezgoda, Modupe O. V. Osinubi, G.S.N. Kia, Abiodun O Ogunniyi, Olugbon A. Saliman, Panayampalli Subbian Satheshkumar, Akin Oyemakinde, Mohammed Abdurrahman, Yemi H. Gbadegesin, Sebastian K Yennan, Babasola O Olugasa, Gloria C Okara, Ryan M. Wallace, Raymond Dankoli, Munir Sani, Lauren Greenberg, Abimbola Aman-Oloniyo, Samson Y Matthias, Christina L. Hutson, Marissa Person, James A. Ellison, Okechukwu Ossai, Olufunmilayo A. Sanni-Adeniyi, Lora Davis
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 7, Pp 1399-1408 (2020)
Emerging Infectious Diseases
Emerging Infectious Diseases
Using questionnaires and serologic testing, we evaluated bat and lyssavirus exposure among persons in an area of Nigeria that celebrates a bat festival. Bats from festival caves underwent serologic testing for phylogroup II lyssaviruses (Lagos bat vi
Autor:
Ki Eun Maeng, Lauren Greenberg, Madhusudana N. Shampur, Jun-Young Lee, Richard Franka, Cheol Min Kim, Modupe O. V. Osinubi, Sun Ju Keum, Soo Young Lee, Ji Min Seo, Hyunjoo Lee, Jung Sun Ahn, Kye Sook Yi, Minsoo Kim, Ji-Young Shin, Pan Kyeom Kim, Min Joo Choo, Charles E. Rupprecht
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 9, p e0256779 (2021)
PLoS ONE, Vol 16, Iss 9, p e0256779 (2021)
Post-exposure prophylaxis (PEP) is highly effective in preventing disease progression of rabies when used in timely and appropriate manner. The key treatment for PEP is infiltration of rabies immune globulin (RIG) into lesion site after bite exposure
Autor:
Barnabas Bakamutumaho, Emily G. Pieracci, Galileu Barbosa Costa, Modupe O. V. Osinubi, Amy T. Gilbert, Sergio Recuenco, Julie M. Cleaton, Victor Tugumizemu, Ryan M. Wallace, Joseph F. Wamala, Laura Adams, Sarah C. Bonaparte
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0251702 (2021)
PLoS ONE
PLoS ONE
Background Rabies is a viral disease of animals and people causing fatal encephalomyelitis if left untreated. Although effective pre- and post-exposure vaccines exist, they are not widely available in many endemic countries within Africa. Since many
Autor:
Jocelyne Pierre-Louis, David W. Lowrance, Marco Antonio Natal Vigilato, John D. Boone, Ryan M. Wallace, Jesse D. Blanton, Pierre Dilius Augustin, Richard Franka, Fleurinord Ludder, Andrecy Liverdieu, Patrick Dely, Modupe O. V. Osinubi, Paul Adrien, Andre Coetzer, Max Millien, Melissa D. Etheart, Roopal Patel, Lillian A. Orciari, Kelly Crowdis, Joanne Lindenmayer, Natael Fenelon
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Haiti, a Caribbean country of 10.5 million people, is estimated to have the highest burden of canine-mediated human rabies deaths in the Western Hemisphere, and one of the highest rates of human rabies deaths in the world. Haiti is also the poorest c
Publikováno v:
Vaccine. 35:4315-4320
In the USA, rabies vaccines (RVs) are licensed for intramuscular (IM) use only, although RVs are licensed for use by the intradermal (ID) route in many other countries. Recent limitations in supplies of RV in the USA reopened discussions on the more
Autor:
C. Lutfy, Melissa D. Etheart, Richard Franka, Jessie L. Dyer, Charles E. Rupprecht, N. Phaimyr Jn Charles, A. Ali, Apollon Destine, N. Saleme, C. Newman, Modupe O. V. Osinubi, V. R. Johnson, Kelly Crowdis, Meseret G. Birhane, Natael Fenelon, Ryan M. Wallace
Publikováno v:
Zoonoses and public health. 65(6)
The highest rate of human rabies deaths reported in the Americas is in Haiti, and most of these deaths result from rabies virus infections that occur after individuals are bitten by infected dogs and do not receive rabies post-exposure prophylaxis. O
Autor:
Victor Tugumizemu, Barnabas Bakamutumaho, Amy T. Gilbert, Sergio Recuenco, Jason M. Mehal, Modupe O. V. Osinubi, Ryan M. Wallace, Jesse D. Blanton, Joseph F. Wamala, Yoshinori Nakazawa
Publikováno v:
Infectious Diseases of Poverty
Infectious Diseases of Poverty, Vol 6, Iss 1, Pp 1-22 (2017)
Infectious Diseases of Poverty, Vol 6, Iss 1, Pp 1-22 (2017)
Background Rabies is a neglected disease despite being responsible for more human deaths than any other zoonosis. A lack of adequate human and dog surveillance, resulting in low prioritization, is often blamed for this paradox. Estimation methods are
Autor:
Andrew J. Nok, Richard Franka, Michael Niezgoda, Xianfu Wu, Charles E. Rupprecht, Modupe O. V. Osinubi, A. B. Ogunkoya
Publikováno v:
Vaccine. 27:7214-7218
Enhancing DNA vaccine effectiveness remains a challenge, especially if the desired goal is immunization efficacy after a single dose. The glycoprotein gene from the rabies virus Evelyn-Rokitnicki-Abelseth (ERA) strain was modified by mutation at amin
Autor:
Ji Young Shin, Shin Jae Chang, Qing Tang, Xiaoyan Tao, Sun Ju Keum, Wang Lihua, Madhusdana Shampur, Pan Kyeom Kim, Man Su Kim, Charles E. Rupprecht, Soo Young Lee, Guodong Liang, William C. Carson, Pengcheng Yu, Sang Tae Park, Mi Jung Park, Modupe O. V. Osinubi, Richard Franka, Lauren Greenberg
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186380 (2017)
PLoS ONE
PLoS ONE
Current post-exposure prophylaxis for rabies virus infection has several limitations in terms of supply, cost, safety, and efficacy. Attempts to replace human or equine rabies immune globulins (HRIG or ERIG) have been made by several companies and in